LexDanaLexDanabeta
Inventor

Jeffrey T. Mihalic

Inventor
San Francisco, CA, US

Overview

30→
Patents
2004–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%
C07BGeneral methods of organic chemistry9%
PatentTitleYear
11,046,680Heteroaryl-substituted triazoles as APJ receptor agonists202110,736,883Triazole furan compounds as agonists of the APJ receptor202010,344,016Bromotriazole intermediates201910,221,162Triazole agonists of the APJ receptor201910,058,550Methods of treating heart failure20189,868,721'Triazole agonists of the APJ receptor'20189,845,310Intermediates for preparing triazole agonists of the APJ receptor20179,751,864'Methods for preparing triazole agonists of the APJ receptor'20179,745,286'Triazole agonists of the APJ receptor'20179,656,997'Triazole agonists of the APJ receptor'20179,656,998'Intermediates for preparing triazole agonists of the APJ receptor'20179,593,129'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20179,573,936'Triazole agonists of the APJ receptor'20179,376,425'Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer'20169,296,736'Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer'20168,980,903'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20158,841,312'Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors'20147,939,538'Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases'20117,799,795'Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders'20107,572,783'Substituted benzofused heterocycles'20097,375,102'Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use'20087,271,271'Imidazolo-related compounds, compositions and methods for their use'20077,253,179'Fused heterocyclic compounds'20077,148,259'Antibacterial agents'20067,125,885'Fused heterocyclic compounds'20067,053,234'Antibacterial agents'20067,045,527'Piperidine derivatives'20066,858,619'Fused heterocyclic compounds'20056,809,104'Fused heterocyclic compounds'20046,780,858'Antibacterial agents'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004Patents assigned to TULARIK INC (2)· patent assignee history
2004–2021Based in San Francisco, CA, US· patent location history
2005–2021Patents assigned to AMGEN INC (26)· patent assignee history
2007–2008Patents assigned to AMGEN SF LLC (2)· patent assignee history
2014Patents assigned to CONNORS RICHARD V (1)· patent assignee history
2014Patents assigned to DEIGNAN JEFFREY (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN INC262005–2021
AMGEN SF LLC22007–2008
TULARIK INC22004
CONNORS RICHARD V12014
DEIGNAN JEFFREY12014
Locations
LocationPatentsSpan
San Francisco, California, US302004–2021